市場調査レポート
商品コード
1105678
ライフサイエンスBPOの世界市場規模:製品タイプ別(医薬品アウトソーシング、医療機器アウトソーシング、契約販売およびマーケティングアウトソーシング、その他)、地域別予測(2022年~2028年)Global Life Sciences BPO Market Size study, By Product Type (Pharmaceutical outsourcing, Medical devices outsourcing, Contract sales and marketing outsourcing, Others), and Regional Forecasts 2022-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
ライフサイエンスBPOの世界市場規模:製品タイプ別(医薬品アウトソーシング、医療機器アウトソーシング、契約販売およびマーケティングアウトソーシング、その他)、地域別予測(2022年~2028年) |
出版日: 2022年07月11日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
|
世界のライフサイエンスBPOの市場規模は、製薬企業や医療機器会社が採用するアウトソーシングの傾向の高まり、製薬業界の成長、臨床研究の増加、医薬品や医療機器に対する研究開発費の増加、創薬のためのAIと機械学習(ML)の統合の進展などによって促進されています。
一方で、既存企業による限定的なアウトソーシングやデータの安全性に関する懸念が、予測期間における同市場の成長を抑制する可能性があります。
当レポートでは、世界のライフサイエンスBPO市場を調査しており、市場の概要、市場分析、製品タイプ・地域別の分析、および競合情勢など、包括的な情報を提供しています。
List of figures
Global Life Sciences BPO Market is valued at approximately USDXX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Life sciences business process outsourcing (BPO) is a delegation of one or more IT-intensive business processes to an external provider for managing and administrating the selected processes based on defined and measurable performance metrics. Life sciences BPO provides a wide range of services in R&D, drug registration, and product launch through a third-party provider. The growing trend of outsourcing employed by pharma and medical device companies, the growth of the pharmaceutical industry, coupled with the increasing number of clinical studies are the primary factors burgeoning the market growth across the globe. For instance, according to Statista analysis, in 2018, the worldwide pharmaceutical sector generated a revenue of USD 1204.8 billion. Also, the amount reached 1423.5 in 2021, which is anticipated to progressively grows in the impending years. Thereby, the flourishing development of the pharmaceutical industry is accelerating global market growth. However, limited outsourcing by established companies and data safety concerns impede the growth of the market over the forecast period of 2022-2028. Also, the rising R&D spending on pharmaceutical and medical devices and the growing integration of AI and machine learning (ML) for drug discovery are anticipated to act as catalyzing factors for the market demand during the forecast period.
The key regions considered for the global Life Sciences BPO Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. Asia-Pacific is the leading region across the world in terms of market share owing to the rising number of skilled professionals and continuously improving healthcare infrastructure. Whereas, Europe is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the surging demand for technologically advanced drug discovery methods, as well as growth of the pharmaceutical and medical device industry, would create lucrative growth prospects for the Life Sciences BPO Market across the European region.
Major market players included in this report are:
Accenture plc
Atos SE
Boehringer Ingelheim GmbH
Catalent, Inc.
Covance, Inc. (Labcorp)
Genpact Ltd.
ICON plc
Infosys Ltd.
Lonza Group
PAREXEL International Corp.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Pharmaceutical outsourcing
Medical devices outsourcing
Contract sales and marketing outsourcing
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Life Sciences BPO Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors